ADPT vs ECL · rev $179.0M vs P/E 35, rev $4.01B
Adaptive Biotechnologies Corp (ADPT) versus Ecolab Inc (ECL) — a side-by-side from cached financials, not a winner call.
Adaptive Biotechnologies Corp (ADPT) is a diagnostics & research company listed on NASDAQ.
Ecolab Inc (ECL) is a specialty chemicals company listed on US.
Latest reported ADPT revenue for 2024-12-31 was $179.0M. Net income was -$159.6M. Revenue was up 5.1% from 2023-12-31 to 2024-12-31. ADPT currently screens at market cap $2.69B.
Latest reported ECL revenue for 2024-12-31 was $4.01B. Net income was $2.13B. Revenue was up 0.2% from 2024-09-30 to 2024-12-31. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
ADPT currently screens at market cap $2.69B. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
Not investment advice. Open the ADPT and ECL stock pages for the full models.
Not investment advice.